This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Boom Or Bubble? Insiders Like The Look Of These 3 Biotech Stocks

Mary-Lynn Cesar, Kapitall: They can be volatile, but are there investing ideas among biotech stocks that insiders are buying?

Biotech stocks are having quite the year. There were over 30 companies with IPOs so far, and the NASDAQ Biotechnology Index has grown by 67.8% over the last twelve months, more than double the 32.1% recorded by the benchmark S&P 500 index.

(Read more on Biotech from Kapitall: Biotechs Climb and Crumble on Catalysts in 2013)

However, the increased investment activity and skyrocketing stock prices have led to much talk of a bursting biotech bubble. Within the last month, Barron's, Bloomberg, Financial Times, Forbes, and The  Wall Street Journal have all discussed the biotech industry, wondering if it's experiencing a bubble or a boom, and when the potential bubble may burst.

This inspired us to run a screen for the investor who may believe that the biotech industry is experiencing a boom, and that there's no bubble in sight. We decided to look for an indicator amongst biotech stocks that good things may still come for these companies.

Investing ideas

To begin, we constructed a universe comprised of biotechnology stocks. We then looked for stocks with significant net insider purchases over the last six months representing 2% of share float or higher.

Since insiders work at the companies in question, they have more knowledge about the firms than outsiders. Therefore, when they use their own money to purchase shares of their company's stock, it may indicate they are bullish about the firm's future and believe current share price is undervalued.

We were left with three stocks on our list:

Click on the interactive chart below to see analyst ratings over time.

Do you think insiders are right with their bullish sentiment towards these stocks? Use this list as a starting point for your own analysis.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,131.86 +47.37 0.28%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,838.6430 +8.1730 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs